Attention has been drawn to the hypothesis that PTX-3 can modulate inflammation, and increased PTX-3 levels in patients with cardiovascular risk may reflect a physiologically protective mechanism associated with the immunoinflammatory response observed in various cardiovascular diseases [28]. This evidence concerns the gene PTX3 and cardiovascular disorder.